The Pennant Group (PNTG) versus Its Rivals Financial Survey

The Pennant Group (NASDAQ:PNTG – Get Free Report) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it contrast to its rivals? We will compare The Pennant Group to similar businesses based on the strength of its valuation, dividends, risk, profitability, institutional ownership, analyst recommendations and earnings.

Insider & Institutional Ownership

85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 6.9% of The Pennant Group shares are held by company insiders. Comparatively, 14.9% of shares of all “Healthcare Providers & Services” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares The Pennant Group and its rivals revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
The Pennant Group $947.71 million $29.58 million 36.67
The Pennant Group Competitors $21.12 billion $301.67 million -2.04

The Pennant Group’s rivals have higher revenue and earnings than The Pennant Group. The Pennant Group is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a breakdown of current recommendations for The Pennant Group and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group 0 1 6 0 2.86
The Pennant Group Competitors 1884 7756 13415 836 2.55

The Pennant Group presently has a consensus target price of $48.75, indicating a potential upside of 34.30%. As a group, “Healthcare Providers & Services” companies have a potential upside of 17.79%. Given The Pennant Group’s stronger consensus rating and higher possible upside, analysts plainly believe The Pennant Group is more favorable than its rivals.

Volatility & Risk

The Pennant Group has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. Comparatively, The Pennant Group’s rivals have a beta of 0.98, indicating that their average share price is 2% less volatile than the S&P 500.

Profitability

This table compares The Pennant Group and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
The Pennant Group 3.05% 10.23% 4.06%
The Pennant Group Competitors 1.61% -135.40% -1.32%

Summary

The Pennant Group beats its rivals on 9 of the 13 factors compared.

The Pennant Group Company Profile

(Get Free Report)

The Pennant Group, Inc. provides healthcare and senior living services through independently operated subsidiaries. Its services include home health and hospice care for people in their homes, as well as senior living options such as assisted living and memory care. Based in Eagle, Idaho, the company operates across multiple U.S. states, with a presence concentrated in the western part of the country. Its local operating teams provide care and support to patients, residents and their families. Pennant became an independent publicly traded company in 2019 after separating from The Ensign Group.

Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.